Silvia Bolland
Appearance
Silvia Bolland | |
---|---|
Scientific career | |
Fields | Biomedicine |
Institutions | National Institute of Allergy and Infectious Diseases |
Silvia Bolland is an American biomedical scientist serving as chief of the autoimmunity and functional genomics section at the National Institute of Allergy and Infectious Diseases.
She earned a Ph.D. in molecular biology from the University of Cantabria and received postdoctoral training at Harvard and Rockefeller University.[1] Her areas of research include the identification of new genetic modifiers of systemic autoimmune disease, dose effect of Toll-like receptor genes and its role in autoimmune pathologies, and inhibitory signaling pathways mediated by the IgG Fc receptor (Fc gamma RIIB) and the phosphoinositol 5-phosphatase (SHIP).[2]
Selected works
- Ono, Masao; Bolland, Silvia; Tempst, Paul; Ravetch, Jeffrey V. (September 1996). "Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FeγRIIB". Nature. 383 (6597): 263–266. Bibcode:1996Natur.383..263O. doi:10.1038/383263a0. ISSN 1476-4687. PMID 8805703. S2CID 4339496.
- Bolland, Silvia; Ravetch, Jeffrey V (August 2000). "Spontaneous Autoimmune Disease in FcγRIIB-Deficient Mice Results from Strain-Specific Epistasis". Immunity. 13 (2): 277–285. doi:10.1016/S1074-7613(00)00027-3. PMID 10981970.
- Ravetch, Jeffrey V.; Bolland, Silvia (April 2001). "IgG Fc Receptors". Annual Review of Immunology. 19 (1): 275–290. doi:10.1146/annurev.immunol.19.1.275. ISSN 0732-0582. PMID 11244038.
References
- ^ "Silvia M. Bolland, Ph.D. | Principal Investigators | NIH Intramural Research Program". irp.nih.gov. Retrieved 2022-11-02.
- ^ "Silvia Bolland, Ph.D." NIH: National Institute of Allergy and Infectious Diseases. 30 December 2016. Retrieved 2021-01-30. This article incorporates text from this source, which is in the public domain.
This article incorporates public domain material from websites or documents of the National Institutes of Health.